See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Natural Disasters
Baseball
Social Media
Democratic Party
Republican Party
Education
Senate
Tariffs
US Politics
Artificial Intelligence
Donald Trump
Soccer
Published • loading... • Updated

#NeOnc Technologies: Shaping the Future of Brain Therapeutics with Strategic Leadership and Financial Backing

Summary by csimarket.com
Navigating New Frontiers in Biotechnology NeOnc Technologies Holdings, Inc. is poised at an exciting juncture in its corporate evolution, marked by significant leadership appointments, strategic financing, and a forthcoming listing on the Nasdaq Global Market. These developments collectively herald a promising trajectory for the biotech company, known for its pioneering work in treating neurological disorders. Leadership Enhancement - Recently, …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
csimarket.comcsimarket.com

#NeOnc Technologies: Shaping the Future of Brain Therapeutics with Strategic Leadership and Financial Backing

Navigating New Frontiers in Biotechnology NeOnc Technologies Holdings, Inc. is poised at an exciting juncture in its corporate evolution, marked by significant leadership appointments, strategic financing, and a forthcoming listing on the Nasdaq Global Market. These developments collectively herald a promising trajectory for the biotech company, known for its pioneering work in treating neurological disorders. Leadership Enhancement - Recently, …

Read Full Article
Express PharmaExpress Pharma

USC-licensed startup NeOnc Technologies gets NASDAQ listing - Express Pharma

A USC-licensed startup, NeOnc Technologies, that developed an intranasal drug delivery system for brain tumors has got listed for the first time on Nasdaq. NeOnc has also announced a strategic partnership with CBCC Global Research, a CRO, to expand clinical trials across 30 FDA-compliant sites in India, facilitating the advancement of its neuro-oncology treatment. NeOnc is based on intellectual property developed by neurosurgeon and NeOnc foun…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Express Pharma broke the news in on Monday, March 31, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Startups

Startups

India

India

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal